FdaApplication

NDA 022116

Back to search

Identifiers

Properties

PropertyValue
applicant_nameVIIV HEALTHCARE CO
application_typeNDA
approval_date2007-06-14

Products (1)

ProductActive ingredientStrengthDosage form
LEXIVAFOSAMPRENAVIR CALCIUMEQ 50MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SUSPENSION;ORAL

1 product